SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-16-000139
Filing Date
2016-11-15
Accepted
2016-11-15 16:30:27
Documents
18
Period of Report
2016-11-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-koctobermor_11152016.htm 8-K 37044
2 EXHIBIT 99.1 nrxoctobermor.htm EX-99.1 4668
3 nrxoctobermor001.jpg GRAPHIC 95535
4 nrxoctobermor002.jpg GRAPHIC 25831
5 nrxoctobermor003.jpg GRAPHIC 14380
6 nrxoctobermor004.jpg GRAPHIC 120696
7 nrxoctobermor005.jpg GRAPHIC 212778
8 nrxoctobermor006.jpg GRAPHIC 139161
9 nrxoctobermor007.jpg GRAPHIC 91291
10 nrxoctobermor008.jpg GRAPHIC 87030
11 nrxoctobermor009.jpg GRAPHIC 90926
12 nrxoctobermor010.jpg GRAPHIC 145463
13 nrxoctobermor011.jpg GRAPHIC 76217
14 nrxoctobermor012.jpg GRAPHIC 82065
15 nrxoctobermor013.jpg GRAPHIC 153767
16 nrxoctobermor014.jpg GRAPHIC 129634
17 nrxoctobermor015.jpg GRAPHIC 121746
18 nrxoctobermor016.jpg GRAPHIC 128620
  Complete submission text file 0001338095-16-000139.txt   2373266
Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 162000036
SIC: 2834 Pharmaceutical Preparations